Literature DB >> 29185013

Assessment of arterially hyper-enhancing liver lesions using virtual monoenergetic images from spectral detector CT: phantom and patient experience.

N Große Hokamp1,2,3, A J Höink4, J Doerner4, D W Jordan5,6, G Pahn7, T Persigehl4, D Maintz4, S Haneder4.   

Abstract

PURPOSE: To investigate a benefit from virtual monoenergetic reconstructions (VMIs) for assessment of arterially hyper-enhancing liver lesions in phantom and patients and to compare hybrid-iterative and spectral image reconstructions of conventional images (CI-IR and CI-SR).
METHODS: All imaging was performed on a SDCT (Philips Healthcare, Best, The Netherlands). Images of a non-anthropomorphic phantom with a lesion-mimicking insert (containing iodine in water solution) and arterial-phase images from contrast-enhanced patient examinations were evaluated. VMIs (40-200 keV, 10 keV increment), CI-IR, and CI-SR were reconstructed using different strengths of image denoising. ROIs were placed in lesions, liver/matrix, muscle; signal-to-noise, contrast-to-noise, and lesion-to-liver ratios (SNR, CNR, and LLR) were calculated. Qualitatively, 40, 70, and 110 keV and CI images were assessed by two radiologists on five-point Likert scales regarding overall image quality, lesion assessment, and noise.
RESULTS: In phantoms, SNR was increased threefold by VMI40keV compared with CI-IR/SR (5.8 ± 1.1 vs. 18.8 ± 2.2, p ≤ 0.001), while no difference was found between CI-IR and CI-SR (p = 1). Denoising was capable of noise reduction by 40%. In total, 20 patients exhibiting 51 liver lesions were assessed. Attenuation was the highest in VMI40keV, while image noise was comparable to CI-IR resulting in a threefold increase of CNR/LLR (CI-IR 1.3 ± 0.8/4.4 ± 2.0, VMI40keV: 3.8 ± 2.7/14.2 ± 7.5, p ≤ 0.001). Subjective lesion delineation was the best in VMI40keV image (p ≤ 0.01), which also provided the lowest perceptible noise and the best overall image quality.
CONCLUSIONS: VMIs improve assessment of arterially hyper-enhancing liver lesions since they increase lesion contrast while maintaining low image noise throughout the entire keV spectrum. These data suggest that to consider VMI screening after arterially hyper-enhancing liver lesions.

Entities:  

Keywords:  Hyper-attenuating liver lesions; Image quality; Spectral detector computed tomography; Virtual monoenergetic images

Mesh:

Year:  2018        PMID: 29185013     DOI: 10.1007/s00261-017-1411-1

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  11 in total

Review 1.  Dual energy computed tomography virtual monoenergetic imaging: technique and clinical applications.

Authors:  Tommaso D'Angelo; Giuseppe Cicero; Silvio Mazziotti; Giorgio Ascenti; Moritz H Albrecht; Simon S Martin; Ahmed E Othman; Thomas J Vogl; Julian L Wichmann
Journal:  Br J Radiol       Date:  2019-04-09       Impact factor: 3.039

2.  Improved Sensitivity and Reader Confidence in CT Colonography Using Dual-Layer Spectral CT: A Phantom Study.

Authors:  Markus M Obmann; Chansik An; Amanda Schaefer; Yuxin Sun; Zhen J Wang; Judy Yee; Benjamin M Yeh
Journal:  Radiology       Date:  2020-07-28       Impact factor: 11.105

3.  Metal artifacts in patients with large dental implants and bridges: combination of metal artifact reduction algorithms and virtual monoenergetic images provides an approach to handle even strongest artifacts.

Authors:  Kai Roman Laukamp; David Zopfs; Simon Lennartz; Lenhard Pennig; David Maintz; Jan Borggrefe; Nils Große Hokamp
Journal:  Eur Radiol       Date:  2019-01-16       Impact factor: 5.315

4.  Dual-layer dual-energy computed tomography for the assessment of hypovascular hepatic metastases: impact of closing k-edge on image quality and lesion detectability.

Authors:  Yasunori Nagayama; Ayumi Iyama; Seitaro Oda; Narumi Taguchi; Takeshi Nakaura; Daisuke Utsunomiya; Yoko Kikuchi; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2018-10-30       Impact factor: 5.315

5.  Virtual monoenergetic images preserve diagnostic assessability in contrast media reduced abdominal spectral detector CT.

Authors:  Simon Lennartz; Nils Große Hokamp; Charlotte Zäske; David Zopfs; Grischa Bratke; Andreas Glauner; David Maintz; Thorsten Persigehl; De-Hua Chang; Tilman Hickethier
Journal:  Br J Radiol       Date:  2020-07-24       Impact factor: 3.039

6.  Generally applicable window settings of low-keV virtual monoenergetic reconstructions in dual-layer CT-angiography of the head and neck.

Authors:  David Zopfs; Simon Lennartz; Nuran Abdullayev; Thorsten Lichtenstein; Kai Roman Laukamp; Robert Peter Reimer; Christoph Kabbasch; Jan Borggrefe; Marc Schlamann; Victor Neuhaus; Nils Große Hokamp
Journal:  Quant Imaging Med Surg       Date:  2021-08

7.  Quantitative accuracy of virtual non-contrast images derived from spectral detector computed tomography: an abdominal phantom study.

Authors:  Jasmin A Holz; Hatem Alkadhi; Kai R Laukamp; Simon Lennartz; Carola Heneweer; Michael Püsken; Thorsten Persigehl; David Maintz; Nils Große Hokamp
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

8.  Spectral Detector CT-Derived Pulmonary Perfusion Maps and Pulmonary Parenchyma Characteristics for the Semiautomated Classification of Pulmonary Hypertension.

Authors:  Roman Johannes Gertz; Felix Gerhardt; Jan Robert Kröger; Rahil Shahzad; Liliana Caldeira; Jonathan Kottlors; Nils Große Hokamp; David Maintz; Stephan Rosenkranz; Alexander Christian Bunck
Journal:  Front Cardiovasc Med       Date:  2022-02-28

9.  Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinoma.

Authors:  Robert Peter Reimer; Nils Große Hokamp; Julius Niehoff; David Zopfs; Simon Lennartz; Mariam Heidar; Roger Wahba; Dirk Stippel; David Maintz; Daniel Pinto Dos Santos; Christian Wybranski
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

10.  Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia using Computed Tomographic Spectral Imaging.

Authors:  Weixia Li; Ruokun Li; Xiangtian Zhao; Xiaozhu Lin; Yixing Yu; Jing Zhang; Kemin Chen; Weimin Chai; Fuhua Yan
Journal:  J Clin Transl Hepatol       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.